Muc21 inhibitors encompass a range of chemicals that can influence the production, secretion, and composition of mucins. These include inhibitors of glycosylation enzymes, which are critical for the post-translational modification of mucins. Mucins are heavily glycosylated proteins, and the process of glycosylation is essential for their proper function and stability. Inhibitors such as Tunicamycin and Benzyl-α-GalNAc can directly affect the glycan chains attached to mucins. Other chemicals, like Brefeldin A and Monensin, disrupt the normal function of the Golgi apparatus, where mucins undergo extensive post-translational modifications including glycosylation.
Additionally, some chemicals listed interfere with the upstream processes that supply the necessary precursors for glycosylation. For instance, 2-Deoxy-D-glucose is a glucose analog that can inhibit glycolysis, thereby potentially limiting the energy and substrates required for glycosylation. Similarly, Cerulenin, by inhibiting fatty acid synthase, affects lipid metabolism which is intertwined with glycosylation pathways due to the lipid-linked oligosaccharides that serve as donors for N-linked glycosylation. Each of these chemicals affects mucins like Muc21 by altering the biochemical pathways they depend on for proper structure and function, rather than by binding directly to the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting the glycosylation of mucins like Muc21. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Inhibits Golgi alpha-mannosidase II, impacting glycan processing of proteins. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi apparatus function, can affect mucin processing and secretion. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Inhibits glucosidases I and II, altering glycan processing in the ER and Golgi. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Glucosidase inhibitor, can affect glycan trimming and mucin maturation. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that alters Golgi pH and cation homeostasis, influencing mucin glycosylation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glucose analog that inhibits glycolysis, can indirectly affect glycosylation processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Raises endosomal pH, which can affect trafficking and processing of glycoproteins. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Fatty acid synthase inhibitor, can indirectly affect glycosylation by altering lipid metabolism. | ||||||